Despite these similarities, we argue that the partial deletion of Esrrg may be a better tool for understanding DAergic vulnerability in PD, considering that shifts in transcriptional programs may be more likely to occur downstream of cellular signaling events in disease (see Fig. 7) and aging rather than isolated effects on Tfam alone. The gene discussed is ESRRG; the disease is Parkinson disease.